Molecular biology analysis in psychiatry is an approach that relies on biological techniques at the molecular level to study psychiatric disorders. It includes the study of expression profiles, DNA, RNA, proteins, and metabolites at the molecular level.

Fig. 1 Genome-wide molecular mechanisms of psychiatric diseases. (Blokhin IO, et al., 2020)

Ace Therapeutics's molecular biology analysis services can help you understand the specific genes, proteins, and metabolic pathways associated with the pathogenesis of a particular psychiatric disorder. For example, when studying autism spectrum disorders, you can identify which aspects are associated with the development of the disease. This is done by examining proteins, gene expression profiles, and metabolites in various neuronal cells.

Our molecular biology analysis can also be applied to study the development of novel drugs. For example, by modulating one or more genes, proteins, and metabolic pathways to develop a novel drug and analyze its effects on the nervous system.

Molecular Biology Services

• Gene Expression Analysis in Psychiatry

We provide gene expression analysis services related to psychiatric disorders to support research in gene expression, RNA (transcriptome) analysis, biomarker identification and validation, and biologics safety testing. Our gene expression analyses help you understand the mechanisms of psychiatric disorders and promote the development of precision treatment strategies for psychiatric disorders.

• Protein Analysis in Psychiatry

We provide protein analysis services for the study of various psychiatric disorders. By studying how drugs bind to specific proteins and the mechanisms that influence their function, we can provide guidance and rationale for the research and design of new drugs. In addition, we can help you understand the mechanisms of signal transduction, transmembrane transport, cellular metabolism, and protein interaction-related biological processes related to psychiatric pathology, thus helping you identify biomarkers and unravel the pathogenesis of psychiatric disorders.

• Autoradiography Services in Psychiatry

We provide specialized services for radioligand binding assays, receptor occupancy studies, and radioautography for the study of psychiatric disorders. We provide a comprehensive assessment of the pathophysiology of psychiatric disorders and data on the mechanism of action of therapeutic compounds through radiographic autoradiography combined with behavioral readings.

• Oxidative Stress Assays in Psychiatry

We offer a variety of oxidative stress assays for tracking different parameters of oxidative stress as well as for detecting the status and activity of key oxidative stress biomarkers. We are committed to helping researchers better monitor the mechanisms and responses to oxidative stress associated with psychiatric disorders.

• Neurotransmitter Analysis in Psychiatry

Neurotransmitters are chemicals in the brain responsible for neural signaling and play an important role in the pathogenesis of psychiatric disorders. We were able to analyze a wide range of neurotransmitters from a large number of biological matrices through an electrochemical platform and subsequent neurochemical bioanalytical tools.

Why Choose Us?

• Help reveal disease mechanisms: Our molecular biology analysis services provide insight into the etiology and pathophysiological mechanisms of psychiatric disorders, probing disease onset and progression from a genetic and biomolecular perspective.
• Provide biomarkers: The diagnosis of psychiatric disorders is mainly based on clinical manifestations, but most of them do not have visible physiopathological alterations. Through our molecular biology analysis, biomarkers can be found to help diagnose and treat certain psychiatric disorders.
• Improve drug development efficiency: Psychotropic drug development requires significant time and funding, and our molecular biology analysis services can help researchers better understand the way drugs interact with specific molecules so that new drugs can be screened and developed more efficiently.

Ace Therapeutics's molecular biology analysis technology can provide a new perspective for the study of psychiatric disorders and the development of novel drugs. If you are interested in our services, please make an inquiry and let us know what you would like to achieve and our team of experts will contact you within one business day to discuss your needs.

Reference

1. Blokhin IO, et al. Molecular mechanisms of psychiatric diseases. Neurobiol Dis. 2020, 146:105136.